The Phaserl


Big Pharma eyes more revenue with potentially dangerous new obesity pill

by Lance Devon, Natural News:

As obesity weighs down over a third of the United States adult population, drug companies are moving in to save the day. Arena pharmaceuticals, along with the FDA’s nod of approval, are set to begin marketing the first FDA approved weight loss drug in 13 years. The drug, lorcaserin, will be marketed in the US as Belviq, a pill designed for those with chronic weight issues with a BMI of 30 or more. It will also be prescribed to those with a BMI of 27 with at least one “weight related” condition such as high blood pressure, type 2 diabetes, or high cholesterol. With projections of obesity to strike half the US population in the next 10 years, this ‘quick fix’ pop-a-pill mindset will do nothing but perpetuate the problem and ignore the root causes.

DEA warns of drugs abuse potential

The U.S. Drug Enforcement Agency has declared lorcaserin a Schedule IV drug, according to the Controlled Substances Act, which now states that this drug has the potential for abuse and dependence.

Read More @

Help us spread the ANTIDOTE to corporate propaganda.

Please follow SGT Report on Twitter & help share the message.

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>